Shares of Colgate-Palmolive (NYSE:CL - Get Free Report) have been assigned an average recommendation of "Moderate Buy" from the twenty-two analysts that are presently covering the company, Marketbeat.com reports. One equities research analyst has rated the stock with a sell rating, nine have issued a hold rating and twelve have given a buy rating to the company. The average 1-year price objective among analysts that have issued ratings on the stock in the last year is $103.63.
Several equities research analysts have weighed in on CL shares. Stifel Nicolaus downgraded Colgate-Palmolive from a "buy" rating to a "hold" rating and lowered their price target for the stock from $105.00 to $101.00 in a report on Monday, October 28th. StockNews.com cut shares of Colgate-Palmolive from a "buy" rating to a "hold" rating in a research note on Thursday. JPMorgan Chase & Co. upped their price target on shares of Colgate-Palmolive from $113.00 to $114.00 and gave the company an "overweight" rating in a research note on Friday, October 11th. TD Cowen lowered their price objective on shares of Colgate-Palmolive from $110.00 to $100.00 and set a "buy" rating for the company in a research note on Wednesday. Finally, Wells Fargo & Company cut their target price on Colgate-Palmolive from $92.00 to $83.00 and set an "underweight" rating on the stock in a research report on Tuesday, January 7th.
Get Our Latest Report on Colgate-Palmolive
Insiders Place Their Bets
In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 45,410 shares of the business's stock in a transaction that occurred on Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the completion of the sale, the chief financial officer now directly owns 36,726 shares in the company, valued at approximately $3,456,283.86. The trade was a 55.29 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.34% of the stock is currently owned by company insiders.
Institutional Trading of Colgate-Palmolive
A number of institutional investors have recently made changes to their positions in the company. Reston Wealth Management LLC acquired a new position in shares of Colgate-Palmolive during the 3rd quarter worth approximately $42,000. Capital Performance Advisors LLP purchased a new position in Colgate-Palmolive during the third quarter worth approximately $53,000. Prospera Private Wealth LLC acquired a new position in Colgate-Palmolive during the third quarter worth $64,000. True Wealth Design LLC grew its holdings in Colgate-Palmolive by 1,460.9% in the 3rd quarter. True Wealth Design LLC now owns 718 shares of the company's stock valued at $75,000 after buying an additional 672 shares in the last quarter. Finally, Continuum Advisory LLC increased its stake in shares of Colgate-Palmolive by 93.4% in the 3rd quarter. Continuum Advisory LLC now owns 762 shares of the company's stock worth $79,000 after acquiring an additional 368 shares during the last quarter. 80.41% of the stock is owned by institutional investors and hedge funds.
Colgate-Palmolive Stock Down 1.2 %
Shares of NYSE:CL traded down $1.08 during trading on Friday, reaching $86.38. The stock had a trading volume of 6,711,117 shares, compared to its average volume of 4,690,402. The firm's 50-day simple moving average is $92.62 and its 200 day simple moving average is $98.06. The company has a current ratio of 1.04, a quick ratio of 0.68 and a debt-to-equity ratio of 9.46. Colgate-Palmolive has a one year low of $79.69 and a one year high of $109.30. The company has a market capitalization of $70.57 billion, a P/E ratio of 24.75, a PEG ratio of 3.31 and a beta of 0.44.
Colgate-Palmolive Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 21st will be issued a $0.50 dividend. The ex-dividend date of this dividend is Tuesday, January 21st. This represents a $2.00 dividend on an annualized basis and a yield of 2.32%. Colgate-Palmolive's payout ratio is 57.31%.
Colgate-Palmolive Company Profile
(
Get Free ReportColgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Recommended Stories
Before you consider Colgate-Palmolive, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Colgate-Palmolive wasn't on the list.
While Colgate-Palmolive currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Keep reading to learn how options trading can help you use the market’s volatility to your advantage.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.